Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy

Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy

Renal cell carcinoma (RCC) is a heterogeneous disease comprising a variety of histological subtypes. Approximately 70–80% of RCC cases are clear cell carcinoma (ccRCC), while the remaining subtypes constitute non-clear cell carcinoma (nccRCC). The medical treatment of RCC has greatly changed in rece...

Full description

Bibliographic Details
Main Authors: Kazutoshi Yamana, Riuko Ohashi, Yoshihiko Tomita
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
renal cell carcinoma
drug therapy
histological subtypes
immunotherapy
biology-driven treatment strategy
Online Access:https://www.mdpi.com/2227-9059/10/11/2840

Internet

https://www.mdpi.com/2227-9059/10/11/2840

Similar Items